|
relative gray value (gene/β-actin), ( ± S)
|
---|
Gene
|
P
|
1
|
2
|
3
|
4
|
5
|
6
|
---|
CD44v6
|
0.386 ± 0.049
|
0.396 ± 0.052
|
0.438 ± 0.115
|
0.210 ± 0.075(1)
|
0.244 ± 0.120(1)
|
0.142 ± 0.064(1)(2)
|
0.117 ± 0.030(1)(3)
|
VEGF-C
|
0.605 ± 0.166
|
0.514 ± 0.083
|
0.398 ± 0.079(1)
|
0.305 ± 0.132(1)(2)
|
0.344 ± 0.038(1)
|
0.095 ± 0.016(1)(3)
|
0.150 ± 0.036(1)
|
MMP-9
|
0.966 ± 0.205
|
1.053 ± 0.222
|
0.997 ± 0.093
|
0.461 ± 0.170(1)
|
0.466 ± 0.121(1)
|
0.244 ± 0.107(1)(2)
|
0.220 ± 0.098(1)(3)
|
- CD44v6: (1) p < 0.05 vs. P, (2) p < 0.05 vs. 3, (3) p < 0.05 vs. 4; VEGF-C: (1) p < 0.05 vs. P, (2) p < 0.05 vs. 2 and 4, (3) p < 0.05 vs. 6; MMP-9: (1) p < 0.05 vs. P, (2) p < 0.05 vs. 3, (3) p < 0.05 vs. 4.
- P, positive control (untreated HeLa cells); 1, Fe3O4 without MFH; 2, Fe3O4 plus MFH; 3, nanosized As2O3 (5 μM)/Fe3O4 plus MFH; 4, 5 μM As2O3; 5, nanosized As2O3 (10 μM)/Fe3O4 plus MFH group; 6, 10 μM As2O3.